The LCOs were generated from the biopsy of the progression disease (PD) lymph node metastasis where the EGFR L858R mutation was still present and the EGFR T790M mutation was absent (Fig. 5c). The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.